4-Chlorobenzo [b] thiophene CAS 66490-33-3 Purity> 98,0% (GC) Brexpiprazole Panengah Pabrik Gambar Diulas

4-Chlorobenzo[b]thiophene CAS 66490-33-3 Purity>98,0% (GC) Brexpiprazole Intermediate Factory

Katerangan pondok:

Ngaran Kimia: 4-Chlorobenzo[b]tiofen

CAS: 66490-33-3

Kamurnian: > 98,0% (GC)

Penampilan: Cairan teu warnaan

Panengah Brexpiprazole (CAS: 913611-97-9)

Kualitas luhur, Produksi komérsial

E-Mail: alvin@ruifuchem.com

Kirim surélék ka kami

Rincian produk

Produk patali

Tag produk

Katerangan:

Ruifu Kimia Supply Brexpiprazole panengah
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo [b] thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl) piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-hiji CAS 913613-82-8
4-Chlorobenzo[b]tiofen CAS 66490-33-3

Sipat Kimia:

Ngaran Kimia	4-Klorobenzo[b]tiofena
sinonim	4-Chloro-Benzo[b]tiofen;4-Chloro-1-Benzothiophene;4-Klorobenzotiofen
Nomer CAS	66490-33-3
Nomer CAT	RF-PI1983
Status Saham	Dina Stok, Skala Produksi Nepi ka Ton
Formula Molekul	C8H5ClS
Beurat Molekul	168.64
merek	Kimia Ruifu

spésifikasi:

Barang	spésifikasi
Penampilan	Cairan teu warnaan
Purity / Métode Analisis	> 98,0% (GC)
Total Kotoran	<2.00%
Spéktrum Infrabeureum	Conforms kana Struktur
NMR	Conforms kana Struktur
Standar tés	Standar Perusahaan
Pamakéan	Panengah Brexpiprazole (CAS: 913611-97-9)

Paket & Panyimpenan:

Bungkusan: Botol Fluorinated, 25kg / Drum, atawa nurutkeun sarat customer urang

Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya sareng Uap

Kaunggulan:

FAQ:

Aplikasi:

4-Chlorobenzo [b] thiophene (CAS: 66490-33-3) mangrupikeun Perantara Brexpiprazole (CAS: 913611-97-9).Brexpiprazole mangrupakeun ubar antipsychotic novel nu boga fungsi minangka serotonin ® dopamin aktivitas modulator sarta geus nunjukkeun efficacy salaku hiji perlakuan adjunctive di penderita karusuhan depressive utama (MDD).Ubar kasebut nunjukkeun profil farmakologis anu unik, bertindak salaku agonis parsial serotonin 5-HT1A sareng reséptor dopamin D2 sareng antagonis pinuh ku 5-HT2A sareng reséptor noradrenalin α1B / 2C, kalayan pangirut subnanomolar anu sami.Ubar, anu dikembangkeun ku Otsuka sareng Lundbeck, disatujuan dina 2015 ku FDA pikeun pengobatan schizophrenia sareng salaku pangobatan tambahan pikeun déprési.Brexpiprazole sacara lega dianggap salaku panerus pikeun obat antipsikotik Otsuka aripiprazole (ngaran dagang Abilify) anu paténna kadaluwarsa dina bulan Agustus 2014.